OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 01, 2013
Preferred-provider relationships are transforming the bio/pharmaceutical industry.
When speaking of partnerships, the discussion typically focuses on the relationship between a pharmaceutical/biopharmaceutical company as the sponsor company and a contract-service provider.
Adherence to GMP in API manufacturing is crucial in determining the safety of drug products.
Innovation resulting in improved productivity continues unabated and is a primary driver for many of the current biopharmaceutical trends.
January 01, 2013
Will international biomanufacturing outsourcing become mainstream in this decade?
December 02, 2012
The quest to build critical mass and broaden capabilities has been a key factor in deal-making.
November 02, 2012
The procurement organization rethinks sourcing for maximum efficiency and results.
Key talks from the recent PDA/FDA regulatory conference highlight room for improvement.
To support global stability practices, fundamental basics must be in place.
October 31, 2012
Patheon will acquire softgel-specialist company Banner Pharmacaps, based in North Carolina in the US, for $255 million